CD133 is the other marker of cancer stem cells that is expressed in more than 50% of cells in many malignancies, including gastric and pancreatic cancers and intrahepatic cholangioca-rcinoma (12). This evidence concerns the gene PROM1 and familial pancreatic carcinoma.